Choksi Laboratories Ltd vs Fortis Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Choksi Laboratories Ltd is ₹ 207.75 as of 23 Oct 15:30 . The P/E Ratio of Choksi Laboratories Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Fortis Healthcare Ltd changed from 39.5 on March 2022 to 57.6 on March 2026 . This represents a CAGR of 7.84% over 5 years The Market Cap of Choksi Laboratories Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Fortis Healthcare Ltd changed from ₹ 15023 crore on March 2021 to ₹ 59988 crore on March 2026 . This represents a CAGR of 25.96% over 6 years The revenue of Choksi Laboratories Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Fortis Healthcare Ltd for the Jun '26 is ₹ 2573 crore as compare to the Mar '26 revenue of ₹ 2375 crore. This represent the growth of 8.34% The ebitda of Choksi Laboratories Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Fortis Healthcare Ltd for the Jun '26 is ₹ 565.5 crore as compare to the Mar '26 ebitda of ₹ 530.45 crore. This represent the growth of 6.61% The net profit of Choksi Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Fortis Healthcare Ltd changed from ₹ 173.98 crore to ₹ 272.8 crore over 9 quarters. This represents a CAGR of 22.13% The Dividend Payout of Choksi Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Fortis Healthcare Ltd changed from 78.45 % on March 2023 to 32.78 % on March 2026 . This represents a CAGR of -19.60% over 4 years .

About Choksi Laboratories Ltd

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services.
CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries.
The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services. The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day.
It provides calibration of production & quality control equipment with traceability to national / international standards.
This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects.

About Fortis Healthcare Ltd

Fortis Healthcare Limited (FHL) is one of the largest healthcare services providers in India with 27 hospitals, ~4,750+ operational beds and 400+ diagnostics centres as of 31 March, 2025.
The Company offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services to patients in areas such as Cardiac Care, Orthopedics, Neurosciences, Oncology, renal care, Gastroenterology and Mother and Child care..
They are delivering quality healthcare services to patients in modern facilities using advanced technology. SRL Limited, a subsidiary of FHL is primarily involved in providing diagnostics services and is amongst the leading diagnostics chains in India with a significant market share in the organized diagnostics segment.

FAQs for the comparison of Choksi Laboratories Ltd and Fortis Healthcare Ltd

Which company has a larger market capitalization, Choksi Laboratories Ltd or Fortis Healthcare Ltd?

Market cap of Choksi Laboratories Ltd is 144 Cr while Market cap of Fortis Healthcare Ltd is 54,356 Cr

What are the key factors driving the stock performance of Choksi Laboratories Ltd and Fortis Healthcare Ltd?

The stock performance of Choksi Laboratories Ltd and Fortis Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Choksi Laboratories Ltd and Fortis Healthcare Ltd?

As of October 25, 2026, the Choksi Laboratories Ltd stock price is INR ₹207.75. On the other hand, Fortis Healthcare Ltd stock price is INR ₹720.0.

How do dividend payouts of Choksi Laboratories Ltd and Fortis Healthcare Ltd compare?

To compare the dividend payouts of Choksi Laboratories Ltd and Fortis Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.